NCT01205074View on ClinicalTrials.gov

¹³C-Methacetin Breath Test (MBT) Methodology Study

PHASE2/PHASE3UnknownINTERVENTIONAL
Timeline

Start Date

September 30, 2010

Conditions
Healthy SubjectsChronic Liver DiseaseCirrhosis
Interventions
DEVICE

13C Methacetin Breath Test

DIETARY_SUPPLEMENT

Grape fruit juice

DRUG

Non selective beta blocker - Propranolol

DIETARY_SUPPLEMENT

Ethanol

Trial Locations (1)

91120

Liver Unit Hadassah Medical Center, Jerusalem

Sponsors

Collaborators (1)

Meridian Bioscience, Inc.
All Listed Sponsors
collaborator

Meridian Bioscience, Inc.

INDUSTRY

lead

Hadassah Medical Organization

OTHER